161 related articles for article (PubMed ID: 25460850)
1. Aqueous-core PEG-coated PLA nanocapsules for an efficient entrapment of water soluble anticancer drugs and a smart therapeutic response.
Cosco D; Paolino D; De Angelis F; Cilurzo F; Celia C; Di Marzio L; Russo D; Tsapis N; Fattal E; Fresta M
Eur J Pharm Biopharm; 2015 Jan; 89():30-9. PubMed ID: 25460850
[TBL] [Abstract][Full Text] [Related]
2. Enhanced in vivo therapeutic efficacy of plitidepsin-loaded nanocapsules decorated with a new poly-aminoacid-PEG derivative.
Lollo G; Hervella P; Calvo P; Avilés P; Guillén MJ; Garcia-Fuentes M; Alonso MJ; Torres D
Int J Pharm; 2015 Apr; 483(1-2):212-9. PubMed ID: 25681727
[TBL] [Abstract][Full Text] [Related]
3. Gemcitabine-loaded biocompatible nanocapsules for the effective treatment of human cancer.
Paolino D; Cosco D; Celano M; Moretti S; Puxeddu E; Russo D; Fresta M
Nanomedicine (Lond); 2013 Feb; 8(2):193-201. PubMed ID: 23094834
[TBL] [Abstract][Full Text] [Related]
4. Biocompatible Glycopolymer Nanocapsules via Inverse Miniemulsion Periphery RAFT Polymerization for the Delivery of Gemcitabine.
Utama RH; Jiang Y; Zetterlund PB; Stenzel MH
Biomacromolecules; 2015 Jul; 16(7):2144-56. PubMed ID: 26027950
[TBL] [Abstract][Full Text] [Related]
5. Polyglutamic acid-PEG nanocapsules as long circulating carriers for the delivery of docetaxel.
Lollo G; Rivera-Rodriguez GR; Bejaud J; Montier T; Passirani C; Benoit JP; García-Fuentes M; Alonso MJ; Torres D
Eur J Pharm Biopharm; 2014 May; 87(1):47-54. PubMed ID: 24530693
[TBL] [Abstract][Full Text] [Related]
6. Polymeric Micelles of PEG-PLA Copolymer as a Carrier for Salinomycin Against Gemcitabine-Resistant Pancreatic Cancer.
Daman Z; Montazeri H; Azizi M; Rezaie F; Ostad SN; Amini M; Gilani K
Pharm Res; 2015 Nov; 32(11):3756-67. PubMed ID: 26228105
[TBL] [Abstract][Full Text] [Related]
7. An innovative hydrogel of gemcitabine-loaded lipid nanocapsules: when the drug is a key player of the nanomedicine structure.
Moysan E; González-Fernández Y; Lautram N; Béjaud J; Bastiat G; Benoit JP
Soft Matter; 2014 Mar; 10(11):1767-77. PubMed ID: 24652455
[TBL] [Abstract][Full Text] [Related]
8. PEGylated squalenoyl-gemcitabine nanoparticles for the treatment of glioblastoma.
Gaudin A; Song E; King AR; Saucier-Sawyer JK; Bindra R; Desmaële D; Couvreur P; Saltzman WM
Biomaterials; 2016 Oct; 105():136-144. PubMed ID: 27521616
[TBL] [Abstract][Full Text] [Related]
9. In vitro and in vivo anti-tumor effects of gemcitabine loaded with a new drug delivery system.
Tong Q; Li H; Li W; Chen H; Shu X; Lu X; Wang G
J Nanosci Nanotechnol; 2011 Apr; 11(4):3651-8. PubMed ID: 21776750
[TBL] [Abstract][Full Text] [Related]
10. Gemcitabine-based polymer-drug conjugate for enhanced anticancer effect in colon cancer.
Liang TJ; Zhou ZM; Cao YQ; Ma MZ; Wang XJ; Jing K
Int J Pharm; 2016 Nov; 513(1-2):564-571. PubMed ID: 27613255
[TBL] [Abstract][Full Text] [Related]
11. Stereocomplex Prodrugs of Oligo(lactic acid)
Tam YT; Huang C; Poellmann M; Kwon GS
ACS Nano; 2018 Jul; 12(7):7406-7414. PubMed ID: 29957934
[TBL] [Abstract][Full Text] [Related]
12. Passively Targeted Curcumin-Loaded PEGylated PLGA Nanocapsules for Colon Cancer Therapy In Vivo.
Klippstein R; Wang JT; El-Gogary RI; Bai J; Mustafa F; Rubio N; Bansal S; Al-Jamal WT; Al-Jamal KT
Small; 2015 Sep; 11(36):4704-22. PubMed ID: 26140363
[TBL] [Abstract][Full Text] [Related]
13. Tailoring the properties of mPEG-PLLA nanoparticles for better encapsulation and tuned release of the hydrophilic anticancer drug.
Surwase SS; Munot NM; Idage BB; Idage SB
Drug Deliv Transl Res; 2017 Jun; 7(3):416-427. PubMed ID: 28324320
[TBL] [Abstract][Full Text] [Related]
14. Modification of polyethylene glycol onto solid lipid nanoparticles encapsulating a novel chemotherapeutic agent (PK-L4) to enhance solubility for injection delivery.
Fang YP; Wu PC; Huang YB; Tzeng CC; Chen YL; Hung YH; Tsai MJ; Tsai YH
Int J Nanomedicine; 2012; 7():4995-5005. PubMed ID: 23055719
[TBL] [Abstract][Full Text] [Related]
15. In vivo drug delivery of gemcitabine with PEGylated single-walled carbon nanotubes.
Razzazan A; Atyabi F; Kazemi B; Dinarvand R
Mater Sci Eng C Mater Biol Appl; 2016 May; 62():614-25. PubMed ID: 26952465
[TBL] [Abstract][Full Text] [Related]
16. Precise engineering of hybrid molecules-loaded macromolecular nanoparticles shows
Liu D; Zhang W; Liu X; Qiu R
Drug Deliv; 2021 Dec; 28(1):776-786. PubMed ID: 33866910
[TBL] [Abstract][Full Text] [Related]
17. PEGylated lipid nanocapsules with improved drug encapsulation and controlled release properties.
Hervella P; Alonso-Sande M; Ledo F; Lucero ML; Alonso MJ; Garcia-Fuentes M
Curr Top Med Chem; 2014; 14(9):1115-23. PubMed ID: 24678710
[TBL] [Abstract][Full Text] [Related]
18. Self-assembled core-shell vascular-targeted nanocapsules for temporal antivasculature and anticancer activities.
Wang Z; Ho PC
Small; 2010 Nov; 6(22):2576-83. PubMed ID: 20976704
[TBL] [Abstract][Full Text] [Related]
19. Preparation, physicochemical characterization and cytotoxicity in vitro of gemcitabine-loaded PEG-PDLLA nanovesicles.
Jia L; Zheng JJ; Jiang SM; Huang KH
World J Gastroenterol; 2010 Feb; 16(8):1008-13. PubMed ID: 20180242
[TBL] [Abstract][Full Text] [Related]
20. Design of Pegylated-Nanocapsules to Diphenyl Diselenide Administration: In Vitro Evidence of Hemocompatible and Selective Antiglioma Formulation.
Ferreira LM; Sari MHM; Cervi VF; Prado VC; Nadal JM; Azambuja JH; da Silveira EF; Nogueira CW; Farago PV; Braganhol E; Cruz L
AAPS PharmSciTech; 2020 Nov; 21(8):307. PubMed ID: 33151442
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
